Drugs / KL001
last change Oct 2025 re-read 3 minutes ago

KL001

Developed for
hemophilia B
Investigated by
Affiliated Hospital of Guangdong Medical University · Zhejiang University

Trials 2

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 0 NCT06125756 Dec 2023 → Sep 2024 hemophilia B Affiliated Hospital of Guangdong Medical University Unknown No outcome recorded
Phase 0 NCT06119659 Nov 2023 → Jun 2024 hemophilia B Zhejiang University Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as KL001 ClinicalTrials.gov intervention name — accepted as the source's own label NCT06125756 ↗
1

NCT06119659 ↗